MXD1 and cancer: One of the major consequences of MYC activation is the extensive reprogramming of the expression pattern of miRNAs in tumor cells, which is closely linked to the modulation of critical pathways associated with cancer etiology, including MYC-MAX-MXD1 and Ras-ERK pathways.